ClearOne Inc Dossier
|
SectorInformation Technology IndustryCommunications Equipment Beta (adjusted)0.44 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $5.00Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $13.4M Shares Outstanding 2.6M diluted Next Earnings Date16 Nov 2026 Last ex-dividend11 Apr 2024 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary ClearOne Inc. has transitioned into a non-operating public shell following the sale of its core intellectual property and product inventory to Biamp Systems in October 2025. The company currently generates zero revenue from continuing operations and is focused entirely on winding down legacy liabilities, servicing remaining product warranties, and seeking a strategic transaction (such as a reverse merger or acquisition of a private operating company). While backed by its majority shareholder, First Finance Ltd., which provided $1.75 million in private placement funding in March 2026, ClearOne faces severe going concern risks and is currently non-compliant with Nasdaq's continued listing standards. The stock represents a highly speculative vehicle whose value depends entirely on the terms of a future strategic transaction. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario ClearOne fails to regain compliance with Nasdaq listing standards and is delisted to the over-the-counter (OTC) market, severely reducing liquidity. The company is unable to find a viable strategic partner, and remaining cash is depleted by public company compliance costs and legacy liabilities, leading to liquidation. Base CaseCentral scenario The company successfully maintains its Nasdaq listing through a compliance plan or temporary exception, manages its remaining wind-down liabilities (including the completed redemption of Class A Preferred Stock and office lease termination), and identifies a private operating company for a reverse merger. First Finance Ltd. continues to support the shell's administrative costs. Bull CaseUpside scenario ClearOne is undergoing a complete strategic transformation by entering into a definitive merger agreement with Cortigent, Inc. (a subsidiary of Vivani Medical). This reverse merger pivots the company away from its legacy, loss-making communications hardware business into a high-growth med-tech and brain-computer interface (BCI) play. The bull case centers on the successful clinical development and commercialization of Cortigent's precision neurostimulation technologies, such as the Orion artificial vision system (which holds FDA Breakthrough Device Designation) and stroke-recovery applications, backed by a planned concurrent $10 million to $15 million capital raise. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |